The global market for Fluoroscopy and Mobile C-Arms is estimated at US$3.0 Billion in 2023 and is projected to reach US$3.9 Billion by 2030, growing at a CAGR of 3.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the fluoroscopy and mobile C-arms market is driven by several factors. Firstly, the continuous advancements in imaging technology, such as the development of flat-panel detectors and AI-powered image analysis, are propelling the demand for these devices. The rising number of minimally invasive and outpatient surgeries is expanding the addressable market for mobile C-arms. Furthermore, regulatory approvals and guidelines are strengthening the business case for adopting advanced fluoroscopy systems. The increasing prevalence of chronic diseases and the aging population are also significant drivers, necessitating frequent diagnostic and therapeutic procedures that rely on real-time imaging.
Additionally, the integration of fluoroscopy in hybrid operating rooms (ORs) and the growing emphasis on radiation dose management are generating further demand. Government initiatives and funding for healthcare infrastructure, coupled with rising awareness and training among healthcare professionals, are sustaining the market's growth trajectory. Lastly, the impact of COVID-19 on elective surgeries has underscored the need for mobile and resilient imaging solutions, further accelerating market expansion.
The growth in the fluoroscopy and mobile C-arms market is driven by several factors. Firstly, the continuous advancements in imaging technology, such as the development of flat-panel detectors and AI-powered image analysis, are propelling the demand for these devices. The rising number of minimally invasive and outpatient surgeries is expanding the addressable market for mobile C-arms. Furthermore, regulatory approvals and guidelines are strengthening the business case for adopting advanced fluoroscopy systems. The increasing prevalence of chronic diseases and the aging population are also significant drivers, necessitating frequent diagnostic and therapeutic procedures that rely on real-time imaging.
Additionally, the integration of fluoroscopy in hybrid operating rooms (ORs) and the growing emphasis on radiation dose management are generating further demand. Government initiatives and funding for healthcare infrastructure, coupled with rising awareness and training among healthcare professionals, are sustaining the market's growth trajectory. Lastly, the impact of COVID-19 on elective surgeries has underscored the need for mobile and resilient imaging solutions, further accelerating market expansion.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Fluoroscopy segment, which is expected to reach US$2.2 Billion by 2030 with a CAGR of a 3.4%. The Full-Size C-Arms segment is also set to grow at 4.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $802.7 Million in 2023, and China, forecasted to grow at an impressive 3.7% CAGR to reach $632.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Fluoroscopy and Mobile C-Arms Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Fluoroscopy and Mobile C-Arms Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Fluoroscopy and Mobile C-Arms Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as GE Healthcare, Hologic, Inc., OrthoScan, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 14 Featured):
- GE Healthcare
- Hologic, Inc.
- OrthoScan, Inc.
- Philips Healthcare
- Shimadzu Corporation
- Siemens Healthineers
- Ziehm Imaging GmbH
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned
- GE Healthcare
- Hologic, Inc.
- OrthoScan, Inc.
- Philips Healthcare
- Shimadzu Corporation
- Siemens Healthineers
- Ziehm Imaging GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 259 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 3 Billion |
| Forecasted Market Value ( USD | $ 3.9 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 7 |
